Delivery Order SPE2DB22D3009-SPE2DB25FBF77
- Not listed
- The Defense Logistics Agency awarded a $10,990.43 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Prevnar 20 vaccine in 0.5 milliliter syringes. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $28,274.55 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5 mL) with an ultimate completion date of August 28, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract represents a continuation of AmerisourceBergen's role as a critical federal medical procurement vendor, particularly...
- The Defense Logistics Agency awarded a $6,752.85 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5mL syringes. This competitively awarded, firm fixed price contract has a completion date of September 4, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply framework with DLA. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $1,633.77 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 Syringe 0.5mL, a pneumococcal vaccine, with an ultimate completion date of August 6, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under a larger contract vehicle. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters...
- The Defense Logistics Agency awarded a $1,633.77 delivery order contract to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Prevnar 20 syringes (0.5mL). This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion and extending through December 2026. The contract requires fulfillment by August 20, 2025, with performance at...
- The Defense Logistics Agency awarded a delivery order valued at $20,174.58 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 vaccine in 0.5mL syringes. The contract was competitively awarded without set-aside designation and is classified as a firm fixed price delivery order with an ultimate completion date of September 25, 2025. AmerisourceBergen's Corporate Office, based in Conshohocken, Pennsylvania, will serve as the place of performance for this procurement. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,535.12 for PREVNAR 20 Syringe 0.5ML on July 11, 2025, with completion scheduled for July 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single-line pharmaceutical procurement under the company's broader relationship...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $18,442.87 by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Prevnar 20 vaccine in 0.5ML syringes. The contract is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a non-competed award. Performance of this contract will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in syringe form (0.5ML) with a ceiling value of $44,740.30 under a firm fixed price contract. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of September 26, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,224.52 for PREVNAR 20 vaccine in 0.5mL syringe format, with a completion deadline of September 19, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and veteran...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBF77Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $62,817.87 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 vaccine in 0.5ml syringes. This competitively awarded, firm fixed-price delivery order is due for completion by September 29, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order falls under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a wide range of medical products to support military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The company's track record of competitively awarded contracts demonstrates its capability to fulfill diverse federal medical supply requirements across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $62.8k | 9/27/25 |